Tenon Medical (NASDAQ:TNON – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, November 13th. Individual that wish to register for the company’s earnings conference call can do so using this link.
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($1.02) EPS for the quarter. The business had revenue of $0.90 million during the quarter. Tenon Medical had a negative net margin of 411.27% and a negative return on equity of 4,819.46%.
Tenon Medical Trading Up 1.7 %
NASDAQ:TNON opened at $3.49 on Wednesday. The company’s fifty day moving average price is $3.62 and its 200-day moving average price is $1.71. Tenon Medical has a 1-year low of $2.80 and a 1-year high of $37.60.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on Tenon Medical
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
See Also
- Five stocks we like better than Tenon Medical
- How to Choose Top Rated Stocks
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- Find and Profitably Trade Stocks at 52-Week Lows
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.